Ampio Pharmaceuticals Inc. | |
Stock Exchange | NYSE |
EPS |
$0.07 |
Market Cap |
$60.79 M |
Shares Outstanding |
141.38 M |
Public Float |
86.6 M |
Address |
373 Inverness Parkway Englewood Colorado 80112 United States |
Employees | - |
Website | http://www.ampiopharma.com |
Updated | 07/08/2019 |
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO. |